RESEARCHER PROFILE

Luís Taborda‐Barata

University of Beira Interior

Asthma and respiratory diseasesAllergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchMobile Health and mHealth Applications

Luís Taborda‐Barata works in Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, Chronic Obstructive Pulmonary Disease (COPD) Research, Mobile Health and mHealth Applications. Recorded institutional associations include University of Beira Interior, Hospital Center of Cova da Beira, Centro de Investigação em Ciências da Saúde.

197Publications

4,929Citations

33H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

Luís Taborda‐Barata

University of Beira Interior

Selected research works

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

High-Affinity IgE Receptor (FcepsilonRI)-Bearing Cells in Bronchial Biopsies From Atopic and Nonatopic Asthma

Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product

Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin

The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment.

Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

Eosinophils and Eosinophil-Associated Cytokines in Allergic Inflammation

IL-4– and IL-5–positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects

Enhanced expression of high-affinity IgE receptor (FcϵRI) α chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells☆☆☆★

Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein

Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19

Biological Effects of Thermal Water-Associated Hydrogen Sulfide on Human Airways and Associated Immune Cells: Implications for Respiratory Diseases

ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020)

Inhaler Technique Education and Exacerbation Risk in Older Adults with Asthma or Chronic Obstructive Pulmonary Disease: A Meta‐Analysis

Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air® real‐world data

ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

CO-RADS: Coronavirus Classification Review

Differential Requirement of ZAP-70 for CD2-Mediated Activation Pathways of Mature Human T Cells

Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study

The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper

A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals

Allergic Rhinitis and Its Impact on Asthma ( ARIA )‐ EAACI Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments